File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives

TitleCRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
Authors
CHAN, YTLU, YWU, JZhang, CTan, HYBian, ZXWang, NFeng, Y
Issue Date2022
Citation
Theranostics, 2022, v. 12, p. 3329-3344 How to Cite?
DOI: http://dx.doi.org/10.7150/thno.71144
Persistent Identifierhttp://hdl.handle.net/10722/312917
ISI Accession Number ID
WOS:000790971700004

 

DC FieldValueLanguage
dc.contributor.authorCHAN, YT-
dc.contributor.authorLU, Y-
dc.contributor.authorWU, J-
dc.contributor.authorZhang, C-
dc.contributor.authorTan, HY-
dc.contributor.authorBian, ZX-
dc.contributor.authorWang, N-
dc.contributor.authorFeng, Y-
dc.date.accessioned2022-05-21T11:53:27Z-
dc.date.available2022-05-21T11:53:27Z-
dc.date.issued2022-
dc.identifier.citationTheranostics, 2022, v. 12, p. 3329-3344-
dc.identifier.urihttp://hdl.handle.net/10722/312917-
dc.languageeng-
dc.relation.ispartofTheranostics-
dc.titleCRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives-
dc.typeArticle-
dc.identifier.emailZhang, C: zttzc@hku.hk-
dc.identifier.emailWang, N: ckwang@hku.hk-
dc.identifier.emailFeng, Y: yfeng@hku.hk-
dc.identifier.authorityWang, N=rp02075-
dc.identifier.authorityFeng, Y=rp00466-
dc.identifier.doi10.7150/thno.71144-
dc.identifier.hkuros333172-
dc.identifier.volume12-
dc.identifier.spage3329-
dc.identifier.epage3344-
dc.identifier.isiWOS:000790971700004-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats